A case of an early-relapsed high-risk T-ALL with high BCL-2 expression on leukemic blasts was successfully treated with decitabine and venetoclax, achieving a CR. We suggest decitabine and venetoclax should be synergistic in BCL2-positive ALL.
Zappone, E., Cencini, E., Defina, M., Sicuranza, A., Gozzetti, A., Ciofini, S., et al. (2020). Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T-cell lymphoblastic leukemia. CLINICAL CASE REPORTS, 8(10), 2000-2002 [10.1002/ccr3.3041].
Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T-cell lymphoblastic leukemia
Sicuranza A.;Gozzetti A.;Bocchia M.
2020-01-01
Abstract
A case of an early-relapsed high-risk T-ALL with high BCL-2 expression on leukemic blasts was successfully treated with decitabine and venetoclax, achieving a CR. We suggest decitabine and venetoclax should be synergistic in BCL2-positive ALL.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
venetoclax.pdf
accesso aperto
Tipologia:
PDF editoriale
Licenza:
Creative commons
Dimensione
218.36 kB
Formato
Adobe PDF
|
218.36 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento:
https://hdl.handle.net/11365/1115022